"Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia"
written by Brian M. Ross, Sandeep Shah, Malcolm Peet,
published by Open Journal of Psychiatry, Vol.1 No.1, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia
[2] Oxidative stress detection by MEMS cantilever sensor array based electronic nose
AIP Conference Proceedings, 2018
[3] MEMS sensor array-based electronic nose for breath analysis—a simulation study
Journal of Breath Research, 2018
[4] Ammonia and ethylene biomarkers in the respiration of the people with schizophrenia using photoacoustic spectroscopy
Journal of Biomedical Optics, 2015
[5] Breath Analysis as a Potential and Non-Invasive Frontier in Disease Diagnosis: An Overview
Metabolites, 2015
[6] SIFT-MS and FA-MS methods for ambient gas phase analysis: developments and applications in the UK
Analyst, 2015
[7] The Relationship between Impaired Methylnicotinate Response and Oxidative Stress in Schizophrenia
Open Journal of Psychiatry, 2014
[8] Breath Ethane Concentrations in Healthy Volunteers Correlate with a Systemic Marker of Lipid Peroxidation but Not with Omega-3 Fatty Acid Availability
Metabolites, 2014
[9] Safety and Tolerability of Edivoxetine for Long-Term Treatment of Major Depressive Disorder in Adult Patients
Open Journal of Psychiatry, 2014
[10] Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry
Rapid Communications in Mass Spectrometry, 2013
[11] The Use of SIFT-MS to Investigate Headspace Aldehydes as Markers of Lipid Peroxidation
Current Analytical Chemistry, 2013
[12] Accuracy profile validation of a new analytical method for butane measurement using headspace-gas chromatography–mass spectrometry
Journal of Chromatography B, 2013